WallachBeth Capital announced that Tenon Medical entered into warrant exercise agreements with an institutional investor covering 572,179 outstanding warrants. The immediate exercise is expected to generate gross proceeds of $2,872,338.58, before financial adviser fees and other expenses. In a private placement, Tenon will issue new immediately exercisable warrants for up to 858,269 shares, equal to 150% of the shares issued through the existing warrant exercise, at an exercise price of $5.02 per share. The new warrants expire five years after issuance. The closing is expected on or about September 14, 2026, subject to customary conditions. WallachBeth Capital is acting as financial adviser, and Tenon has agreed to file a registration statement covering resale of shares issuable upon exercise of the new warrants.